Health Secretary Francisco Duque III announced that the Philippines has sealed the deal for some 25 million doses of the COVID-19 vaccine from Chinese firm Sinovac, with the first batch expected to arrive by February 2021.
“We sealed the deal with Sinovac for 25 million with early 50,000 doses by February, 950,000 by March and 2 to 3 million in succeeding months ’til December with 25 million doses. This is in addition to AstraZeneca as confirmed by Sec. Galvez,” said Duque in a report by Mai Bermudez on GMA’s “24 Oras Weekend“.
Netizens were asking for a clarification as to how the government arrived with the decision of using Sinovac which is more expensive and less effective based on reports and studies. The #SINOVAC trended online.
Dr. Tony Leachon on his Twitter asked the following question:
“How do we justify government’s order of Sinovac , which is less efficacious 50 % , more expensive vs Pfizer ‘s 95% efficacy rate and Astra 70-90 % efficacy rate ? It would be interesting to know the selection guidelines.”
How do we justify government’s order of Sinovac , which is less efficacious 50 % , more expensive vs Pfizer ‘s 95% efficacy rate and Astra 70-90 % efficacy rate ? It would be interesting to know the selection guidelines. https://t.co/8gRI1ty0qg pic.twitter.com/CmMWFmgdQ1
— Tony Leachon MD (@DrTonyLeachon) January 11, 2021
(Photo source: https://www.cnbc.com/)
You must be logged in to post a comment Login